Julie Bolcaen

Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 07, 2026

Absorbed doses to single cells from radionuclides Tb-161, Pd-103, Pd-109, and Er-165 in different cellular compartments and neighbour cells.

Absorbed doses to single cells from radionuclides Tb-161, Pd-103, Pd-109, and Er-165 in different cellular compartments and neighbour cells.

Journal: Physics in medicine and biology

Published: June 03, 2025

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy.

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 24, 2025

Establishment of Primary Adult Skin Fibroblast Cell Lines from African Savanna Elephants (Loxodonta africana).

Establishment of Primary Adult Skin Fibroblast Cell Lines from African Savanna Elephants (Loxodonta africana).

Journal: Animals : an open access journal from MDPI

Published: June 20, 2023

Biodosimetry, can it find its way to the nuclear medicine clinic?

Biodosimetry, can it find its way to the nuclear medicine clinic?

Journal: Frontiers in nuclear medicine

Published: April 21, 2023

Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.

Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 14, 2023

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy.

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 20, 2022

Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer.

Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 20, 2022

Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma.

Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma.

Journal: Cancers

Published: February 24, 2022

An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes.

An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes.

Journal: Journal of visualized experiments : JoVE

Published: January 10, 2022

DNA damage response of haematopoietic stem and progenitor cells to high-LET neutron irradiation.

DNA damage response of haematopoietic stem and progenitor cells to high-LET neutron irradiation.

Journal: Scientific reports

Published: July 26, 2021

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 28, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026